Companies / BOC Sciences / Glenzocimab
BOC Sciences

Glenzocimab | BOC Sciences

(0) Write Review

Glenzocimab is an antibody fragment that inhibits the action of platelet glycoprotein VI (GPVI). Glenzocimab has the potential therapeutic effect on acute ischaemic stroke.

Reviews

(0) | Be the first to review this product
No reviews yet

ABOUT THE COMPANY

BOC Sciences
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
Scientific Products
  • See More
    • Upcoming Virtual Events
    Upcoming Webinars